The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

New Sleep Aid Belsomra Now Approved

by The GoodRx Pharmacist on September 5, 2014 at 2:09 pm

Belsomra (suvorexant) was approved by the FDA in August for patients with insomnia, including trouble falling and staying asleep.

When will Belsomra be available?
Belsomra is expected to be available in late 2014 or early 2015.

What type of medication is Belsomra?
Belsomra is the first drug in a new class of medications recently approved by the FDA known as orexin receptor antagonists. Many other current insomnia meds, including Ambien (zolpidem) are GABA agonists.

How does it work?
Belsomra inhibits the effect of orexin. Orexin is a chemical in the brain that plays a part in keeping you awake.

Want more information? Check out this article!

How is Belsomra usually taken?
Belsomra tablets have been approved in the following four strengths: 5 mg, 10 mg, 15 mg, 20 mg.

The recommended dose for Belsomra is 10mg once nightly within 30 minutes of going to bed when you are able to get at least 7 hours of sleep.

Are there any side effects?

The most commonly reported side effect of Belsomra is drowsiness.

Who should not take Belsomra?
Belsomra is not for anyone who experiences extreme daytime sleepiness and sudden irresistible episodes of sleep also known as narcolepsy.

Will Belsomra be a controlled substance like insomnia medications?

Yes. The DEA has proposed that Belsomra be controlled as a schedule IV substance, and it is undergoing review at this time.

Some other schedule IV controlled substances include Ambien (zolpidem), Xanax (alprazolam), Valium (lorazepam), and Soma (carisoprodol).

According to the DEA, schedule IV controlled substances are have a low potential for abuse and low risk of dependence.

Want more information?

You can also sign up for updates on Belsomra here.


Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.